(Q34063143)

30 July 2017

title

Detecting an overall survival benefit that is derived from progression-free survival (English)

1 reference

30 July 2017

Kristine R Broglio

1

1 reference

30 July 2017

Donald A Berry

series ordinal

2

1 reference

30 July 2017

language of work or name

English

0 references

publication date

9 November 2009

1 reference

Journal of the National Cancer Institute

30 July 2017

published in

1 reference

30 July 2017

volume

101

1 reference

30 July 2017

issue

23

1 reference

30 July 2017

page(s)

1642-1649

1 reference

Progression-free survival is a surrogate for survival in advanced colorectal cancer

30 July 2017

cites work

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4137232

Surrogate end points for median overall survival in metastatic colorectal cancer: literature-based analysis from 39 randomized controlled trials of first-line chemotherapy.

5 July 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4137232

Surrogate markers and survival in women receiving first-line combination anthracycline chemotherapy for advanced breast cancer

5 July 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4137232

Evaluation of tumor response, disease control, progression-free survival, and time to progression as potential surrogate end points in metastatic breast cancer.

5 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP369

When you look matters: the effect of assessment schedule on progression-free survival

21 January 2018

1 reference

12 December 2020

The relationship between progression-free and post-progression survival in treating four types of metastatic cancer

1 reference

12 December 2020

Trouble at the office

1 reference

12 December 2020

Use of progression-free survival as a surrogate marker in oncology trials: some regulatory issues

1 reference

12 December 2020

Exploring and validating surrogate endpoints in colorectal cancer

1 reference

12 December 2020

Identifiers

DOI

10.1093/JNCI/DJP369

1 reference

30 July 2017

1 reference

30 July 2017

1 reference